Supplementary Table 14 from EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell–Dependent Manner

作者：Lily L. Nguyen, Zachary L. Watson, Raquel Ortega, Elizabeth R. Woodruff, Kimberly R. Jordan, Ritsuko Iwanaga, Tomomi M. Yamamoto, Courtney A. Bailey, Francis To, Shujian Lin, Fabian R. Villagómez, Abigail D. Jeong, Saketh R. Guntupalli, Kian Behbakht, Veronica Gibaja, Nausica Arnoult, Edward B. Chuong, Benjamin G. Bitler · 年份：2026 · DOI：10.1158/1541-7786.32714245 · 研究领域：PARP inhibition in cancer therapy、CAR-T cell therapy research、Signaling Pathways in Disease

<p>Hallmark pathways negatively enriched in ID8-R cells treated with combinatory EZM8266/Olaparib compared to EZM8266 alone.</p>